Dihematoporphyrin Ether (Porfimer Sodium)
543
relevant articles (37 outcomes,
80 trials/studies)
found for this Drug
Description:
The purified component of HEMATOPORPHYRIN DERIVATIVE, it consists of a mixture of oligomeric porphyrins. It is used in photodynamic therapy (HEMATOPORPHYRIN PHOTORADIATION); to treat malignant lesions with visible light and experimentally as an antiviral agent. It is the first drug to be approved in the use of PHOTODYNAMIC THERAPY in the United States.
Also Known As:
Porfimer Sodium; Photofrin; Dihematoporphyrin Ester; Photofrin II; Ether, Dihematoporphyrin; DHP Ether; Porfimer; 21H,23H-Porphine-2,18-dipropanoic acid, 7-(1-(1-(8,12-bis(2-carboxyethyl)-17-(1-hydroxyethyl)-3,7,13,18-tetramethyl-21H,23H-porphin-2-yl)ethoxy)ethyl)-12-(1-hydroxyethyl)-3,8,13,17-tetramethyl-
Relationship Network
Drug Context: Research Results